Information for Health Professionals

ASCIA resources for health professionals include Guidelines, Position Papers/Statements, Action Plans, Treatment Plans, Management Plans, Checklists and e-training courses.  

Quick links for this page

Allergic Rhinitis

• ASCIA Allergic Rhinitis e-training for health professionals Updated March 2022
• ASCIA Allergic Rhinitis e-training for pharmacists Updated March 2022
• ASCIA Clinical Update - Allergic Rhinitis Currently being updated
  
• ASCIA Treatment Plan - Allergic Rhinitis
• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
• ASCIA Position Paper - Chronic Rhinosinusitis with Nasal Polyps New November 2021
• References - Chronic Rhinosinusitis with Nasal Polyps A-L New November 2021
• References - Chronic Rhinosinusitis with Nasal Polyps M-Z New November 2021
• References - Allergic Rhinitis New November 2021 

Allergy Prevention and Infant Feeding 

• ASCIA Allergy Prevention e-training for health professionals  
• Overview - Infant feeding and allergy prevention
• ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021
• ASCIA Clinical Update Infant Feeding and Allergy Prevention 
• ASCIA Guidelines - Infant feeding and allergy prevention 
• ASCIA Stepwise management plan for eczema 
• ASCIA Information on how to introduce solid foods to babies for allergy prevention 
  
• ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy 
• References - Allergy Prevention

Anaphylaxis

• ASCIA Anaphylaxis e-training for health professionals Updated September 2021
  
• ASCIA Anaphylaxis refresher e-training for health professionals New February 2022
• ASCIA Anaphylaxis e-training for pharmacists Updated September 2021
• ASCIA Anaphylaxis refresher e-training for pharmacists New February 2022
• ASCIA Guidelines - Acute Management of Anaphylaxis Updated July 2021
  
• ASCIA Guidelines - Acute Management of Anaphylaxis in Pregnancy 
• ASCIA Guidelines - Adrenaline (Epinephrine) Injector Prescription Updated March 2022
• ASCIA Guidelines Summary - Adrenaline (Epinephrine) Injector Prescription Updated March 2022 
• ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare
• ASCIA Anaphylaxis Resources Overview   
• ASCIA Checklists - Anaphylaxis 
• ASCIA Event record for allergic reactions 
• ASCIA Checklist - Transitioning patients from paediatric to adult services 
• ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis 
• References - Anaphylaxis New June 2021

Drug (Medication) Allergy

• ASCIA Penicillin Allergy etraining for health professionals
• Drug (Medication) Allergy Hub
• ASCIA Consent Form - Antibiotic Allergy Challenges New March 2022
• ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021
• ASCIA Record for Drug (Medication) Allergy Updated June 2021
• ASCIA Drug (Medication) Allergy Terms New August 2020
• ASCIA Consensus Statement - Penicillin Allergy Updated August 2020
• ASCIA Consensus Statement - Cephalosporin Allergy New July 2021 (available to Members only) 
• ASCIA Drug allergy pre-clinic information template (available to Members only)
• ASCIA Clinical Update - Antibiotic Allergy

Food Allergy

• ASCIA Food Allergy e-training for health professionals Updated November 2021
• ASCIA Food Allergy e-training for pharmacists Updated November 2021
• ASCIA Position Paper - Food Allergen Challenges New March 2022
• ASCIA Consent Form - Food Allergen Challenges New March 2022
• ASCIA Position Paper - Oral Immunotherapy (OIT) for Food Allergy New April 2021
• ASCIA Guide - Milk Substitutes in Cow’s Milk (Dairy) Allergy Updated March 2022
• ASCIA Dietary Guides for Food Allergy  
• ASCIA Information HP - Lupin Allergy
• ASCIA Food Allergen Challenge Protocols (available to Members only)
• References - Oral Immunotherapy (OIT) for Food Allergy 
• References - Food Allergy Updated March 2022
• References - Food Allergen Challenges New March 2022

Immunodeficiency

• Primary Immunodeficiencies (PID) e-training for health professionals 
• Immunoglobulin Replacement Therapy (IRT) e-training for health professionals New March 2022
• Hereditary Angioedema (HAE) e-training for health professionals  In development 
• ASCIA Immunodeficiency Strategy for Australia and New Zealand
• Immunodeficiency Overview
  
• ASCIA Position Statement - COVID-19 Prophylaxis in People with Immune Deficiencies New May 2022
• ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) New September 2021 
• ASCIA Webinar - HAE
• ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) 
• ASCIA Clinical Update - Primary Immunodeficiencies (PID) 
  
• ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) 
  
• ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital 
• ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
• ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
  
• ASCIA SCIg Treatment Plan 
  
• ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 
  
• ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy 
• ASCIA SCIg Competency Training Checklists New May 2022
• ASCIA ID Register How to access information (available to Members Only)
• References - Immunodeficiency 
• References - Hereditary Angioedema (HAE) 

Immunisation

• ASCIA Guidelines - vaccination of the egg allergic individual 
• ASCIA COVID-19 vaccine information New March 2021

Insect Allergy      

• ASCIA Guide - Venom Immunotherapy, References and Consent Form 
• ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
• ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
• ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
• ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
• Information about Venom Immunotherapy availability

Latex Allergy

• ASCIA Guidelines - Management of Latex-Allergic Individuals

Skin

• ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
• ASCIA Action Plan for Eczema Updated March 2022
• ASCIA Stepwise Management Plan for Eczema Updated March 2022
• ASCIA Position Paper Atopic Dermatitis (Eczema) In development
• ASCIA Position Paper - Chronic Spontaneous Urticaria (CSU)
• References - Chronic Spontaneous Urticaria (CSU) 
• References - Atopic Dermatitis In development

Tests

• Laboratory Investigation of Allergic Diseases New December 2020
• ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
• ASCIA Skin Prick Testing (SPT) Guide for Health Professionals 
• ASCIA Food Allergen Challenge Protocols (available to Members only)
• References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021

External Documents

• RCPA - Pathology Tests - this list is searchable and provides basic information on a wide range of pathology tests across all disciplines.
• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
• Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
• Australian Prescriber Anaphylaxis Wall Chart
• Australian Academy of Science - The science of immunisation
• APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency 
• Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
• European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool 

For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information

Content updated May 2022